-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Eton Pharmaceuticals, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q3 2017 to Q2 2024.
- Eton Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$3.04M, a 167% decline year-over-year.
- Eton Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$6.69M, a 2758% decline year-over-year.
- Eton Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$936K, a 89.6% increase from 2022.
- Eton Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$9.02M, a 361% decline from 2021.
- Eton Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$1.96M, a 93% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)